Description: In the Health Affairs article “Towards A National Action Plan To Improve Representation In Clinical Trials,” co-authored by the MRCT Center’s Barbara Bierer, the authors address the critical need for increased diversity in clinical research to enhance health outcomes for underrepresented populations. They propose a comprehensive national strategy that includes policy reforms, community engagement, and the integration of diverse perspectives in trial design and implementation.
The article discusses the importance of creating educational materials to improve public understanding of clinical research data, particularly in light of misinformation during the COVID-19 pandemic. It emphasizes the need for transparency and clarity in addressing issues like data privacy and the ethical sharing of information. Modern tools such as videos and infographics can make clinical research more accessible and build trust with patients and the public.
Description: Mark Barnes and colleagues at Ropes & Gray, and Barbara Bierer published an article that discusses the impact of PubPeer, an online platform that publicizes suspected data integrity concerns, on the research misconduct process and the institutional challenges of handling anonymous comments within current regulations. The authors propose processes to ensure that credible allegations are rigorously assessed while reducing burden on institutions tasked with their investigation.
Published in:Essentials of Translational Pediatric Drug Development (Academic Press)
Description: Mariana Kruger, Moji Adeyeye, and Barbara Bierer co-authored a book chapter entitled “Pediatric drug development issues during public health emergencies” in the book Essentials of Translational Pediatric Drug Development. In their chapter, the authors outline the regulatory and ethical issues that arise during public health emergencies, focusing on pediatric drug development.
